Program

In-person AND virtual! – We are pioneering a new conference format that will connect in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR is pushing the boundaries of innovation to design an event that works in today’s quickly changing environment. 

In-person registration included the full virtual experience, and virtual-only attendees will be able to tune into live in-person sessions and/or watch captured in-person sessions on-demand in addition to having a variety of virtual-only sessions to attend.

Valuing the Fear of COVID-19 Contagion

Speaker(s)

Poudel N, AlMahasis S, Simpson S, Ngorsuraches S
Auburn University Harrison School of Pharmacy, Auburn, AL, USA

Presentation Documents

OBJECTIVES: To value the fear of COVID-19 contagion.

METHODS: A cross-sectional, web-based discrete choice experiment was conducted among 500 U.S. adults. A Bayesian efficient design was used to generate choice sets. Each choice set contained two hypothetical COVID-19 vaccine alternatives described by seven attributes—the chance of infection, the chance of having severe symptoms from infection, the protection duration, the chance of mild to moderate adverse events from vaccination, the chance of serious adverse events from vaccination, the chance of future exposure to COVID-19 as a result of vaccination, and out-of-pocket cost—and no vaccine as a reference alternative. Mixed logit (ML) and latent class (LC) models were developed. Willingness-to-pay (WTP) for eliminating the possibility of COVID-19 exposure was calculated to value the fear of contagion.

RESULTS: ML model showed all attributes were significantly associated with the preferences for COVID-19 vaccines and captured significant preference heterogeneity for all attributes. Overall, WTP for no chance of COVID-19 exposure as a result of vaccination was $9,966, compared to the medium chance of exposure. LC model revealed two participant classes. All attributes were significantly important for participants in class 1 (average class probability 75%), while all attributes, except the chance of infection, the chance of having severe symptoms from infection, and the chance of either mild to moderate or serious adverse events from vaccination, were significant for participants in class 2. Class 1 had higher proportions of infected (44%) and fully vaccinated (84%) participants. The participants in class 1 were willing to pay higher than those in class 2 ($9,460 vs. $2,651) for no chance of COVID-19 exposure.

CONCLUSIONS: This study affirmed that people valued the elimination of the possibility of COVID-19 exposure (fear of contagion) in addition to other benefits and risks of COVID-19 vaccines. However, preference heterogeneity was observed.

Code

EE471

Topic

Economic Evaluation, Health Technology Assessment, Methodological & Statistical Research, Patient-Centered Research

Topic Subcategory

Novel & Social Elements of Value, Stated Preference & Patient Satisfaction, Survey Methods, Value Frameworks & Dossier Format

Disease

Vaccines